It is a pharma private limited company based in Pune, Maharashtra, India, established in 2020.
2020 | Pune, Maharashtra, India | ActiveSamproj Pharma Private Limited, a active private limited company, was established on 18 November 2020 in Pune, Maharashtra, India. Engaging in drug formulation & development within the manufacturing sector, it holds CIN: U85100PN2020PTC196107. Registered under ROC Roc Pune. it is unlisted. It has an authorized capital of ₹1.50 M and a paid-up capital of ₹0.10 M.
Employing 18 professional, Its leadership includes Jaleelahmed Bakhtiyar Ahmed Dafdar (Director), Amol Arunrao Chaudhari (Director), Prafulla Surajmal Somani (Director). Past directors included Jaleelahmed Bakhtiyar Ahmed Dafdar, Amol Arunrao Chaudhari. It holds ₹2.00 M open charges and no settled loans. Its latest AGM occurred on 30 September 2025, with the balance sheet filed on 31 March 2025. It is based at Flat-101 Avalon Society Sun City Road Sinhgad Road Anandnagar Pune City, Pune, Maharashtra, 411051.
U85100PN2020PTC196107
196107
18 November 2020
₹1.50 M
₹0.10 M
Roc Pune
Unlisted
Active
Explore comprehensive insights into Samproj Pharma Private Limited — covering financial performance, compliance records, Competitor, shareholding patterns, directors, key metrics, and litigation history. Unlock to see detailed insights and stay informed.
Access Report
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
| Jaleelahmed Bakhtiyar Ahmed Dafdar | Director | 02 Dec 2020 | Current |
| Amol Arunrao Chaudhari | Director | 02 Dec 2020 | Current |
| Prafulla Surajmal Somani | Director | 18 Nov 2020 | Current |
| Santosh Ramashankar Mishra | Director | 18 Nov 2020 | Current |
| Sameer Bajare | Director | 18 Nov 2020 | Current |
| Name | Designation | Cessation | Status |
|---|---|---|---|
| Pramod Abcsdd | Additional Director | 06 Dec 2021 | Past |
| Pramod Abcsdd | Additional Director | 06 Dec 2021 | Past |
Discover detailed profiles of directors and KMP - Unlock leadership insights today!
Samproj Pharma Private Limited, for the financial year ended 2024, experienced no change in revenue, with a 0% increase. The company also saw a no change in profitability, with a 0% increase in profit. The company's net worth witnessed no change by increase of 0%.
| Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue | |||||||
| Revenue from Operations | |||||||
| Total Assets | |||||||
| Profit or Loss | |||||||
| Net Worth | |||||||
| EBITDA |
Unlock access to Samproj Pharma's control and ownership data, Corporate Shareholding Patterns, Funding (security allotment) details, Foreign Institutional Investor information, Directors and Key Management Personnel (KMP) Remuneration, Group Structure, Overseas Direct Investment and other pertinent data.
Reveal ownership structures and financial performance - Get instant access now!
₹2,000,000.00
₹0
| Date | Lender | Amount | Status |
|---|---|---|---|
| 26 Mar 2024 | Others | ₹2.00 M | Open |
Explore comprehensive loan charge details -
Samproj Pharma has a workforce of 18 employees as of Feb 04, 2025. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Gain comprehensive insights into the Deals and Valuation data of Samproj Pharma, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Samproj Pharma's trajectory.
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
Progress on Samproj Pharma Private Limited last Annual general meeting of members was held on 30 Sep 2025 as per latest MCA records. was documented.
The activity Samproj Pharma Private Limited has filed its annual Financial statements for the year ended 31 Mar 2025 with Roc Pune. was completed.
Progress on A charge with Others amounted to Rs. 2.00 M with Charge ID 100915128 was registered on 26 Mar 2024. was documented.
The activity Jaleelahmed Bakhtiyar Ahmed Dafdar was appointed as a Director was appointed as a Director on 02 Dec 2020 & has been associated with this company since 5 years 23 days . was completed.
Amol Arunrao Chaudhari was appointed as a Director was appointed as a Director on 02 Dec 2020 & has been associated with this company since 5 years 23 days . was recorded as a recent event.
Progress on Prafulla Surajmal Somani was appointed as a Director was appointed as a Director on 18 Nov 2020 & has been associated with this company since 5 years 1 month . was documented.
The CIN of Samproj Pharma Private Limited is U85100PN2020PTC196107.
Samproj Pharma Private Limited is headquartered at Flat-101 Avalon Society Sun City Road Sinhgad Road Anandnagar Pune City, Pune, Maharashtra, 411051.
Samproj Pharma Private Limited was incorporated on 18 November 2020.
The current directors of Samproj Pharma Private Limited are
The primary industry of Samproj Pharma Private Limited is Manufacturing.
Samproj Pharma Private Limited is unlisted.
The authorized capital of Samproj Pharma Private Limited is ₹1.50 M, and the paid-up capital is ₹0.10 M.
Search company & director profiles for free and gain access to critical business data.
Company Details
+91-XXXXXXXXXX